329 related articles for article (PubMed ID: 15358702)
1. Surfactant proteins in pulmonary alveolar proteinosis in adults.
Brasch F; Birzele J; Ochs M; Guttentag SH; Schoch OD; Boehler A; Beers MF; Müller KM; Hawgood S; Johnen G
Eur Respir J; 2004 Sep; 24(3):426-35. PubMed ID: 15358702
[TBL] [Abstract][Full Text] [Related]
2. Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis.
Kobayashi M; Takeuchi T; Ohtsuki Y
Pathol Int; 2008 Mar; 58(3):203-7. PubMed ID: 18251786
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of surfactant protein production in a mouse model of secondary pulmonary alveolar proteinosis.
Shibasaki M; Hashimoto K; Okamoto M; Hayashi Y; Imaizumi K; Hashimoto N; Ozaki N; Yokoi T; Takagi K; Hasegawa Y; Shimokata K; Kawabe T
Am J Respir Cell Mol Biol; 2009 May; 40(5):536-42. PubMed ID: 18931325
[TBL] [Abstract][Full Text] [Related]
4. [The pulmonary expression of granulocyte-macrophage colony-stimulating factor and surfactant protein in adult idiopathic pulmonary alveolar proteinosis].
Zhou XM; Bai JW; Cai HR; Wu HY; Chen J
Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):832-5. PubMed ID: 16316563
[TBL] [Abstract][Full Text] [Related]
5. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary alveolar proteinosis in SCID mice.
Jennings VM; Dillehay DL; Webb SK; Brown LA
Am J Respir Cell Mol Biol; 1995 Sep; 13(3):297-306. PubMed ID: 7654386
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids.
Hattori A; Kuroki Y; Katoh T; Takahashi H; Shen HQ; Suzuki Y; Akino T
Am J Respir Cell Mol Biol; 1996 Jun; 14(6):608-19. PubMed ID: 8652189
[TBL] [Abstract][Full Text] [Related]
8. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis.
Carraway MS; Ghio AJ; Carter JD; Piantadosi CA
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326
[TBL] [Abstract][Full Text] [Related]
9. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
Huizar I; Kavuru MS
Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
[TBL] [Abstract][Full Text] [Related]
10. [Clinical, biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism: SP-B deficiency and alveolar proteinosis].
Tredano M; Blic JD; Griese M; Fournet JC; Elion J; Bahuau M
Ann Biol Clin (Paris); 2001; 59(2):131-48. PubMed ID: 11282516
[TBL] [Abstract][Full Text] [Related]
11. Effects of proteinosis surfactant proteins on the viability of rat alveolar macrophages.
Shen HQ; Duan CX; Li ZY; Suzuki Y
Am J Respir Crit Care Med; 1997 Nov; 156(5):1679-87. PubMed ID: 9372693
[TBL] [Abstract][Full Text] [Related]
12. SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.
Douda DN; Farmakovski N; Dell S; Grasemann H; Palaniyar N
Orphanet J Rare Dis; 2009 Dec; 4():29. PubMed ID: 20030831
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary surfactant and tuberculosis.
Chroneos ZC; Midde K; Sever-Chroneos Z; Jagannath C
Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S10-4. PubMed ID: 20006297
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Lipidomics in Pulmonary Alveolar Proteinosis.
Griese M; Bonella F; Costabel U; de Blic J; Tran NB; Liebisch G
Am J Respir Crit Care Med; 2019 Oct; 200(7):881-887. PubMed ID: 31002528
[No Abstract] [Full Text] [Related]
15. Pulmonary alveolar proteinosis.
Wang T; Lazar CA; Fishbein MC; Lynch JP
Semin Respir Crit Care Med; 2012 Oct; 33(5):498-508. PubMed ID: 23001804
[TBL] [Abstract][Full Text] [Related]
16. Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage.
Alberti A; Luisetti M; Braschi A; Rodi G; Iotti G; Sella D; Poletti V; Benori V; Baritussio A
Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):817-20. PubMed ID: 8810625
[TBL] [Abstract][Full Text] [Related]
17. Congenital alveolar proteinosis in the Netherlands: a report of five cases with immunohistochemical and genetic studies on surfactant apoproteins.
de la Fuente AA; Voorhout WF; deMello DE
Pediatr Pathol Lab Med; 1997; 17(2):221-31. PubMed ID: 9086529
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic lung lavages in children and adults.
Paschen C; Reiter K; Stanzel F; Teschler H; Griese M
Respir Res; 2005 Nov; 6(1):138. PubMed ID: 16303053
[TBL] [Abstract][Full Text] [Related]
19. Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis.
Doyle IR; Davidson KG; Barr HA; Nicholas TE; Payne K; Pfitzner J
Am J Respir Crit Care Med; 1998 Feb; 157(2):658-64. PubMed ID: 9476887
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein B in type II pneumocytes and intra-alveolar surfactant forms of human lungs.
Brasch F; Johnen G; Winn-Brasch A; Guttentag SH; Schmiedl A; Kapp N; Suzuki Y; Müller KM; Richter J; Hawgood S; Ochs M
Am J Respir Cell Mol Biol; 2004 Apr; 30(4):449-58. PubMed ID: 12972403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
